OpenAlex
PricingAboutJobs
Log inGet started
Work

Three times weekly glatiramer acetate in relapsing–remitting multiple sclerosis

HTML

Year: 2013
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Annals of Neurology
DOI: 10.1002/ana.23938
Authors: Omar Khan, Peter Rieckmann, Alexey Boyko, Krzysztof Selmaj, Robert Zivadinov, GALA Study Group
Institutions: Wayne State University, Friedrich-Alexander-Universität Erlangen-Nürnberg, University of Bamberg, Pirogov Russian National Research Medical University, Medical University of Lodz, University at Buffalo, State University of New York
Language: English

Topic: Multiple Sclerosis Research Studies
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: glatiramer acetate, relapsing-remitting multiple sclerosis, subcutaneous administration, relapse prevention, gadolinium-enhancing lesions, T2 lesions, Expanded Disability Status Scale, injection site reactions, treatment efficacy and safety
SDG: Good health and well-being

Open Access status: closed

Funder: Teva Pharmaceutical Industries
OpenAlex ID: W1580917658
FWCI: 16.94
Cites: 14
Cited by: 239
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security